Antipodes Partners’s PubMatic PUBM Stock Holding History

Antipodes Partners’s Portfolio PUBM Stock Details PUBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,065	Closed	-$158K	–	143
2025 Q3	$158K	Buy	+19,065	New	+$194K	﹤0.01%	80

Other funds holding PUBM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GHC

Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Antipodes Partners's PUBM Position: Q4 2025 in Review

Antipodes Partners sold out of PubMatic (PUBM) in Q4 2025, closing a stake of 19,065 shares — an estimated $158K sold.

Antipodes Partners first reported a position in PUBM in Q3 2025 and held it in 1 quarter. The position peaked at $158K in Q3 2025. 152 funds tracked by Wall St. Rank hold PUBM as of Q4 2025.

Antipodes Partners reported no remaining PubMatic position as of Q4 2025 after selling out during the quarter.
Antipodes Partners sold 19,065 PubMatic shares in Q4 2025, an estimated $158K.
Antipodes Partners first reported a position in PubMatic in Q3 2025 and held it in 1 quarter.
Antipodes Partners's PubMatic position peaked at $158K in Q3 2025.
152 funds tracked by Wall St. Rank held PubMatic as of Q4 2025.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.